Autologous Bone Marrow and Peripheral Blood Stem Cell Transplantation in Multiple Myeloma
- 1 January 1996
- journal article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 14 (4) , 378-391
- https://doi.org/10.3109/07357909609012166
Abstract
(1996). Autologous Bone Marrow and Peripheral Blood Stem Cell Transplantation in Multiple Myeloma. Cancer Investigation: Vol. 14, No. 4, pp. 378-391.Keywords
This publication has 39 references indexed in Scilit:
- Interferon-α 2b Added to Melphalan-Prednisone for Initial and Maintenance Therapy in Multiple MyelomaAnnals of Internal Medicine, 1996
- Induction of Immune Responses in Patients with B-Cell Lymphoma against the Surface-Immunoglobulin Idiotype Expressed by Their TumorsNew England Journal of Medicine, 1992
- Toward a Cure for Multiple Myeloma?New England Journal of Medicine, 1991
- Maintenance Treatment with Recombinant Interferon Alfa-2b in Patients with Multiple Myeloma Responding to Conventional Induction ChemotherapyNew England Journal of Medicine, 1990
- VAD‐based regimens as primary treatment for multiple myelomaAmerican Journal of Hematology, 1990
- GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATIONThe Lancet, 1989
- AUTOGRAFT USING PERIPHERAL BLOOD STEM CELLS COLLECTED AFTER HIGH DOSE MELPHALAN IN HIGH RISK MULTIPLE MYELOMABritish Journal of Haematology, 1988
- High-Dose Glucocorticoid Treatment of Resistant MyelomaAnnals of Internal Medicine, 1986
- Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating AgentsNew England Journal of Medicine, 1984
- HIGH-DOSE INTRAVENOUS MELPHALAN FOR PLASMA-CELL LEUKAEMIA AND MYELOMAThe Lancet, 1983